Literature DB >> 12956893

Concept, mechanisms and therapeutics of angiogenesis in cancer and other diseases.

Tayade Pralhad1, Saraf Madhusudan, Kale Rajendrakumar.   

Abstract

Angiogenesis supports normal physiology as well as contributing to the progression of various diseases including cancer. Determination of the key role of angiogenesis in cancer has led to much optimism for the development of targeted drugs without cytotoxic side-effects. Currently, research in angiogenesis therapy is robust, with the discovery of a growing number of pro- and anti-angiogenic molecules. More time, however, is required to be able to elucidate the complex interactions among these molecules, how they affect vasculature and their functions in different environments. As we learn more about the molecular mechanisms of angiogenesis, a number of effective methods to treat cancer and other diseases will be developed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12956893     DOI: 10.1211/0022357021819

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  28 in total

Review 1.  Targeting the Angiopoietin-2/Tie-2 axis in conjunction with VEGF signal interference.

Authors:  Nikolett M Biel; Dietmar W Siemann
Journal:  Cancer Lett       Date:  2014-10-12       Impact factor: 8.679

2.  Evaluation of 68Ga-labeled iNGR peptide with tumor-penetrating motif for microPET imaging of CD13-positive tumor xenografts.

Authors:  Mingxuan Zhao; Weidong Yang; Mingru Zhang; Guoquan Li; Shengjun Wang; Zhe Wang; Xiaowei Ma; Fei Kang; Jing Wang
Journal:  Tumour Biol       Date:  2016-05-24

Review 3.  Paclitaxel targets VEGF-mediated angiogenesis in ovarian cancer treatment.

Authors:  Bin Ai; Zhixin Bie; Shuai Zhang; Ailing Li
Journal:  Am J Cancer Res       Date:  2016-08-01       Impact factor: 6.166

4.  Microenvironment of a tumor-organoid system enhances hepatocellular carcinoma malignancy-related hallmarks.

Authors:  Yang Wang; Kazuki Takeishi; Zhao Li; Eduardo Cervantes-Alvarez; Alexandra Collin de l'Hortet; Jorge Guzman-Lepe; Xiao Cui; Jiye Zhu
Journal:  Organogenesis       Date:  2017-05-26       Impact factor: 2.500

Review 5.  Combining anaerobic bacterial oncolysis with vaccination that blocks interleukin-10 signaling may achieve better outcomes for late stage cancer management.

Authors:  Guoying Ni; Tianfang Wang; Lin Yang; Yuejian Wang; Xiaosong Liu; Ming Q Wei
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

6.  Bioreductively Activatable Prodrug Conjugates of Combretastatin A-1 and Combretastatin A-4 as Anticancer Agents Targeted toward Tumor-Associated Hypoxia.

Authors:  Blake A Winn; Laxman Devkota; Bunnarack Kuch; Matthew T MacDonough; Tracy E Strecker; Yifan Wang; Zhe Shi; Jeni L Gerberich; Deboprosad Mondal; Alejandro J Ramirez; Ernest Hamel; David J Chaplin; Peter Davis; Ralph P Mason; Mary Lynn Trawick; Kevin G Pinney
Journal:  J Nat Prod       Date:  2020-03-20       Impact factor: 4.050

7.  Urea Derivatives in Modern Drug Discovery and Medicinal Chemistry.

Authors:  Arun K Ghosh; Margherita Brindisi
Journal:  J Med Chem       Date:  2019-12-02       Impact factor: 7.446

8.  Molecular imaging in oncology.

Authors:  A S K Dzik-Jurasz
Journal:  Cancer Imaging       Date:  2004-10-21       Impact factor: 3.909

9.  Mesoporous silica nanoparticle delivery of chemically modified siRNA against TWIST1 leads to reduced tumor burden.

Authors:  James Finlay; Cai M Roberts; Juyao Dong; Jeffrey I Zink; Fuyuhiko Tamanoi; Carlotta A Glackin
Journal:  Nanomedicine       Date:  2015-06-24       Impact factor: 5.307

10.  Cellular cancer vaccines: an update on the development of vaccines generated from cell surface antigens.

Authors:  Petr G Lokhov; Elena E Balashova
Journal:  J Cancer       Date:  2010-11-29       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.